Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

antibody_tests

COVID-19 antibody tests are being used by the NHS without proper assessment, experts warn

June 25, 2020 Business Services, Research and Development COVID-19, antibodies, antibody, coronavirus

Coronavirus antibody tests that are beginning to be used by NHS and care staff have been distributed without adequate assessment, …
News
shutterstock_273326141

Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal

June 24, 2020 Research and Development, Sales and Marketing Gilead, Pionyr, pharma

Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …
News
3806537611_b006ec40bf_c

UK health leaders urge “rapid review” of COVID-19 preparedness as England relaxes lockdown

June 24, 2020 Research and Development COVID-19, England, UK, coronavirus

British Prime Minister Boris Johnson announced an extensive rollback of existing lockdown measures to restrict the spread of COVID-19 in …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 24, 2020 Research and Development COVID, COVID-19, coronavirus

Coronavirus news this week sees treatments for existing diseases being tested in COVID-19 patients, with Roche’s rheumatoid arthritis drug Actemra …
News
johnsons_baby_powder_massage

Johnson & Johnson loses bid to overturn baby powder cancer case

June 24, 2020 Research and Development Johnson and Johnson, talc, talc powder

Johnson & Johnson have had a bid to overturn a verdict that blamed the company’s baby powder for giving women …
News
home_office

UK Home office reclassifies Epidyolex as a Schedule 5 drug

June 24, 2020 Research and Development CBD, cannabiodiol, cannabis

The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …
News
gilead-sciences

Gilead to investigate inhaled formulation of promising COVID-19 therapy remdesivir

June 23, 2020 Manufacturing and Production, Research and Development COVID-19, Gilead, remdesivir

Gilead is intent on pushing the applications of its antiviral drug remdesivir after it has shown efficacy in the treatment …
News
pexels-photo-3044623_araruna

How is COVID-19 impacting the rare disease community?

June 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
Feature
shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …
News

Roche’s Tecentriq improves pathological complete response in triple-negative breast cancer at Phase 3

June 19, 2020 Medical Communications, Research and Development Cancer, Genentech, Roche, breast cancer, tecentriq

 
News
lilly_building_with_american_flag_web

Lilly’s Verzenio combo tops Pfizer’s Ibrance and is first CDK4/6 inhibitor to show benefit in HR+,HER2- early breast cancer

June 18, 2020 Research and Development Eli Lilly, Pfizer, Verzenio, breast cancer, ibrance

 
News

Roche’s rheumatoid arthritis drug Actemra shows no benefit in COVID-19 pneumonia

June 18, 2020 Research and Development Actemra, COVID-19, Roche, coronavirus

Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing …
News

FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer

June 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer

The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …
News
type_2

New data from diabetes prevention programme shows a reduction of type 2 diabetes

June 17, 2020 Research and Development diabetes, type 2 diabetes

The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …
News
dexamethasone_matthew_horwoodgetty_images

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

June 17, 2020 Research and Development COVID-19, University of Oxford, coronavirus, dexamethasone

The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026